한글목차

에소테릭 검사 시장 규모는 2023년 259억 달러에서 2030년 549억 달러에 달하고, 예측 기간 동안 11.3%의 CAGR을 기록할 것으로 예상됩니다.

그림 1. 에소테릭 검사 세계 시장 점유율(%), 지역별, 2023년

기술과 의학 연구의 발전으로 고도로 전문화된 진단 검사가 개발됨에 따라 최근 에소테릭 검사 분야가 큰 주목을 받고 있습니다. 에소테릭 검사란 일반적으로 시행되지 않고 전문 장비, 전문 지식 및 해석이 필요한 임상 검사를 말합니다. 이러한 검사는 희귀 질환의 진단, 치료 효과 모니터링, 개인 맞춤형 의료 솔루션 제공에 활용되는 경우가 많습니다.

세계 에소테릭 검사 시장은 만성 질환의 유병률 증가, 유전자 검사의 발전, 개인 맞춤형 의료에 대한 수요 증가 등의 요인으로 인해 크게 성장하고 있습니다. 에소테릭 검사는 유전자 돌연변이, 바이오마커 및 기타 분자 이상을 식별하여 질병을 조기에 발견하고 치료하는 데 중요한 역할을 합니다.

시장 역학:

세계 에소테릭 검사 시장은 주로 암, 심혈관 질환, 자가면역 질환과 같은 만성 질환의 발병률 증가에 의해 주도되고 있습니다. 에소테릭 테스트는 의료 전문가가 이러한 질병과 관련된 특정 유전자 변이 및 바이오마커를 식별하여 조기 진단 및 개별화된 치료 계획을 수립할 수 있도록 돕습니다. 또한, 정밀의료와 표적치료의 도입이 확대되면서 에소테릭 검사에 대한 수요를 더욱 촉진하고 있습니다.

그러나 에소테릭 검사는 고가의 비용, 불충분한 보상 정책 등의 문제에 직면해 있습니다. 에소테릭 검사는 특수 장비와 전문 지식이 필요하기 때문에 비용이 많이 드는 경우가 많습니다. 또한, 보험사의 보험 적용이 제한적이라는 점도 특히 개발도상국에서 이러한 검사의 보급을 가로막고 있습니다.

이러한 도전에도 불구하고, 시장에는 몇 가지 성장 기회가 있습니다. 예방의학에 대한 관심이 높아지고 질병 조기 발견의 이점에 대한 인식이 높아짐에 따라 세포검사에 대한 수요가 증가할 것으로 예상됩니다. 또한, 차세대 시퀀싱 및 분자 진단과 같은 기술의 발전은 에소테릭 검사의 정확성과 효율성을 향상시켜 시장 확대의 새로운 길을 열어줄 가능성이 높습니다.

본 조사의 주요 특징

• 본 보고서는 2022년을 기준 연도로 하여 예측 기간(2023-2030년)의 시장 규모와 연평균 성장률(CAGR %)을 포함한 세계 에소테릭 검사 시장을 상세히 분석했습니다.
• 또한 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에 대한 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략 등에 대한 중요한 고려 사항도 제공합니다.
• 이 보고서의 인사이트를 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 유형화, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자는 세계 에소테릭 검사 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 할 수 있습니다.

목차

제1장 조사 목적과 가정

• 조사 목적
• 가정
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
• 만성질환이나 감염증 이환율 상승
  • 성장 억제요인
• 고액의 비용과 불충분한 상환
  • 기회
• POC(Point of Care) 에소테릭 검사
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 발매/승인
• PEST 분석
• Porters 분석
• 인수합병 시나리오

제4장 에소테릭 검사 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 신종 코로나바이러스 감염증(COVID-19) 역학
• 공급측과 수요측 분석
• 경제적 영향

제5장 에소테릭 검사 시장, 유형별, 2018-2030년

• 서론
• 내분비학
• 종양학
• 분자진단학
• 신경내과
• 면역학
• 유전자 검사
• 기타

제6장 에소테릭 검사 시장, 기술별, 2018-2030년

• 서론
• 질량분석법
• 실시간 PCR
• 유세포 분석
• 화학발광
• ELISA
• 방사면역측정법
• 기타

제7장 에소테릭 검사 시장, 서비스 프로바이더별, 2018-2030년

• 서론
• 독립형 연구소와 표준 실험실
• 병원 기반 검사기관
• 전문 클리닉
• 기타

제8장 에소테릭 검사 시장, 지역별, 2018-2030년

• 서론
• 북미
• 미국
• 캐나다
• 유럽
• 영국
• 독일
• 이탈리아
• 프랑스
• 스페인
• 러시아
• 기타 유럽
• 아시아태평양
• 중국
• 인도
• 일본
• ASEAN 국가
• 호주
• 한국
• 기타 아시아태평양
• 라틴아메리카
• 브라질
• 멕시코
• 아르헨티나
• 기타 라틴아메리카
• 중동
• GCC 국가
• 이스라엘
• 기타 중동
• 아프리카
• 북아프리카
• 중앙아프리카
• 남아프리카공화국

제9장 경쟁 상황

• LabCorp
• Quest Diagnostics
• OPKO Health
• Miraca Holdings
• Myriad Genetics
• Sonic Healthcare
• Cardio Diagnostics Holdings, Inc
• Veravas
• BPGbio, Inc.
• Fulgent Genetics
• Alveo Technologies, Inc.
• R.L. Diagnostics

제10장 섹션

• 조사 방법
• 출판사 소개

영문목차

The esoteric testing market size is expected to reach US$ 54.9 billion by 2030, from US$ 25.9 million in 2023, at a CAGR of 11.3% during the forecast period.

Figure 1. Global Esoteric Testing Market Share (%), by Region, 2023

The field of esoteric testing has gained significant attention in recent years, as advancements in technology and medical research have allowed for the development of highly specialized diagnostic tests. Esoteric testing refers to laboratory tests that are not commonly performed and require specialized equipment, expertise, and interpretation. These tests are often used to diagnose rare diseases, monitor treatment effectiveness, and provide personalized healthcare solutions.

The global esoteric testing market is witnessing substantial growth, driven by factors such as the increasing prevalence of chronic diseases, advancements in genetic testing, and the growing demand for personalized medicine. Esoteric testing plays a crucial role in identifying genetic mutations, biomarkers, and other molecular abnormalities that can help in the early detection and treatment of diseases.

Market Dynamics:

The global esoteric testing market is primarily driven by the rising incidence of chronic diseases, such as cancer, cardiovascular diseases, and autoimmune disorders. Esoteric tests enable healthcare professionals to identify specific genetic mutations and biomarkers associated with these diseases, facilitating early diagnosis and personalized treatment plans. Moreover, the growing adoption of precision medicine and targeted therapies further fuels the demand for esoteric testing.

However, the market faces certain challenges, including the high cost of esoteric tests and the lack of reimbursement policies. Esoteric tests are often expensive due to the specialized equipment and expertise required for their execution. Additionally, the limited coverage by insurance providers hinders the widespread adoption of these tests, particularly in developing regions.

Despite these challenges, the market presents several opportunities for growth. The increasing focus on preventive healthcare and the rising awareness about the benefits of early disease detection are expected to drive the demand for esoteric testing. Furthermore, advancements in technology, such as next-generation sequencing and molecular diagnostics, are likely to enhance the accuracy and efficiency of esoteric tests, opening new avenues for market expansion.

Key Features of the Study:

• This report provides an in-depth analysis of the global esoteric testing market, including market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• Key companies covered as a part of this study include LabCorp, Quest Diagnostics, OPKO Health, Miraca Holdings, Myriad Genetics, Sonic Healthcare, Cardio Diagnostics Holdings, Inc, Veravas, BPGbio, Inc., Fulgent Genetics, Alveo Technologies, Inc., and S.R.L. Diagnostics
• Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global esoteric testing market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global esoteric testing market

Esoteric Testing Market Segmentation

• By Type
  • Endocrinology
  • Oncology
  • Molecular Diagnostics
  • Neurology
  • Immunology
  • Genetic Testing
  • Others
• By Technology
  • Mass Spectrometry
  • Real Time PCR
  • Flow Cytometry
  • Chemiluminescence
  • ELISA
  • Radioimmunoassay
  • Others
• By Service Provider
  • Independent & Reference Labs
  • Hospital-based Labs
  • Specialty Clinics
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Top Companies in Esoteric Testing Market
  • LabCorp
  • Quest Diagnostics
  • OPKO Health
  • Miraca Holdings
  • Myriad Genetics
  • Sonic Healthcare
  • Cardio Diagnostics Holdings, Inc
  • Veravas
  • BPGbio, Inc.
  • Fulgent Genetics
  • Alveo Technologies, Inc.
  • S.R.L. Diagnostics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Esoteric Testing, By Type
  • Market Esoteric Testing, By Technology
  • Market Esoteric Testing, By Service Provider
  • Market Esoteric Testing, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Rising prevalence of chronic and infectious diseases
  • Restraints
• High costs and inadequate reimbursements
  • Opportunities
• Point-of-care esoteric testing
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Esoteric Testing Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Esoteric Testing Market, By Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Endocrinology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Molecular Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Immunology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Genetic Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Esoteric Testing Market, By Technology, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019- 2030
  • Segment Trends
• Mass Spectrometry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Real Time PCR
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Flow Cytometry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Chemiluminescence
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• ELISA
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Radioimmunoassay
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Esoteric Testing Market, By Service Provider, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019- 2030
  • Segment Trends
• Independent & Reference Labs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Hospital-based Labs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Esoteric Testing Market, By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2019-2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• LabCorp
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Quest Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• OPKO Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Miraca Holdings
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Myriad Genetics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Sonic Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Cardio Diagnostics Holdings, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Veravas
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• BPGbio, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Fulgent Genetics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Alveo Technologies, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• R.L. Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us